Delivery Order SPE2DB22D9207-SPE2DB24FH4VY
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, with a potential value of $2,291.36. The order has a completion date of February 12, 2024 and was awarded on January 22, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA to...
- This firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the purchase of EXPAREL 266 MG/20 ML VIAL 20ML. The order, valued at $9,948.88, has a completion date of July 25, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML, with a potential value of $4,974.44 and a completion date of February 2, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to the federal government, particularly...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $27,404.34 delivery order is for the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML. The order has a completion date of February 5, 2024 and was awarded on January 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with DLA to provide a variety of pharmaceutical and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products, with a potential value of $149,286.60. The order has a completion date of February 16, 2023 and was awarded on January 26, 2023. DMS Pharmaceutical Group holds a variety of federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The total potential value of this order is $24,881.10, with a completion date of January 11, 2024. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with the Defense Logistics Agency to supply a variety of pharmaceutical and medical products to...
- This is a $7,461.66 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, to be delivered by July 15, 2024. DMS Pharmaceutical Group Inc. is the prime contractor and there are no noted subcontractors. This order is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999, which allows the DLA to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,291.36 order is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML pharmaceutical products. The award is part of a larger DLA medical supply contract vehicle, with a ceiling value of up to $499,999,999, that allows the agency to issue delivery orders for a wide range of pharmaceutical items to support military...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $5,711.28, has a completion date of May 30, 2024 and was awarded on May 8, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The order has a potential value of $2,487.22 and a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to support military treatment facilities worldwide under...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB24FH4VYDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML, with a potential value of $9,948.88 and a completion date of January 29, 2024. DMS Pharmaceutical Group holds a variety of federal contracts and indefinite delivery vehicles with DLA to supply pharmaceuticals and medical products in support of military treatment facilities worldwide. This specific delivery order is issued against one of DMS Pharmaceutical Group's existing contracts with DLA to provide necessary pharmaceutical items and medical supplies on a firm fixed price basis to fulfill the routine needs of military treatment centers supported by DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 1/5/24 |